Ch10. Peds Oto Flashcards
Waldeyer’s Ring
Circle of lymphoid tissue including palatine/faucial tonsils, pharyngeal tonsils/adenoids, lingual tonsils, tubal tonsils of Gerlach (near fossa of Rosenmuller); lateral bands and posterior pharynegal wall complete the ring
Arterial supply to palatine tonsils
- Lingual artery (dorsal lingual br)
- Facial artery (ascending palatine and tonsillar arteries)
- Ascending pharyngeal artery
- Maxillary artery (greater palatine and descending palatine arteries
Venous drainage of tonsils
Lingual and pharyngeal veins (internal jugular vein)
Lymphatic drainage from tonsils
No afferent lymphatics, drainage into superior deep cervical and jugular digastric lymph nodes
Innervation to the tonsils
- Anterior pillar (CN X; palatoglossus)
- Posterior pillar (CNX; palatopharyngeus)
- Tonsillar fossa (CN IX, X; superior constrictors)
Histology/tonsillar zones (1st)
- Reticular epithelium: foreign material presented to lymphatic cells via 10-30 cryps/tonsil (blind tubules of squamous epithelium) -> antigen presenting cells (M-cells) -> lymphoid germinal center -> interdigitating dendritic cells and macrophages -> helper T cells -> memory B-cells (nasopharynegal or systemic migratino) and plasma cells (crypts)
Histology/tonsillar zones (2nd)
- Extrafollicular area: contains T-cells
Histology/tonsillar zones (3rd)
- Lymphoid follicle: composed of the mantzle zone (mature B-cells) and the germinal center (active B-cells)
What encapsulates the tonsils?
Tonsils encapsulated by special portions of pharyngobasilar fascia
Arterial supply to the adenoids
Ascending pharyngeal artery from external carotid, minor branches from maxillary artery (ascending pharyngeal branch), facial artery (ascending palatine artery), thyrocervical trunk (ascending cervical), artery of the pterygoid canal
Venous drainage from the adenoids
Pharyngeal veins -> facial and IJ
Innervation to the adenoids
CN IX, X
Histology of the adenoids
Ciliated pseudostratified columnar, stratified squamous, and transitional layers
Organisms of acute tonsillitis
Most commonly Group A beta-hemolytic streptococci, Moraxella, and H. influenzae; less common organisms include Bacteroides, staphylococci, E. coli, diphtheria, syphilis, Neisseria, and viruses (EBV, adenovirus, influenza A and B)
Phases of tonsillitis
Tonsillar erythema -> exudative tonsillitis -> follicular tonsillitis (yellow spots corresponding to lymphatic follicles) -> cryptic tonsillitis (chronic infection)
Chronic adenoiditis pathophyz and SSx
Typically a polymicrobial infection; may be related to reflux, especially in children (difficult to distinguish from sinusitis)
SSx: persistent nasal discharge, malodorous breath, nasal obstruction (snoring), association with recurrent otitis media and sinusitis
How to determine hyponasal speech (i.e. adenoid hyperplasia)?
Pinch nose does not change speech, “M” words
What is adenoid facies?
Open mouthed, dark circles under eyes, flattened midface, high arched palate
What to suspect if unilateral tonsillar hyperplasia?
Consider neoplasm (lymphoma, leukemia, SCC) or unusual infections (M. tuberculosis, atypical mycobacteria, actinomycosis, fungal)
What to do in acute respiratory distress from obstructive tonsillar and adenoid hypertrophy?
Use nasal trumpet (rarely requires intubation) with a short course of corticosteroids, prolonged course of Abx (3-6 weeks) or nasal corticosteroid sprays for adenoid hyperplasia; tonsillectomy and adenoidectomy for definitive therapy
PTA pathophyz( two)
- Spread of infection outside tonsillar capsule into the peritonsillar space
- Infection in a peritonsillar minor salivary gland (Weber gland), controversial
Typically begins at superior pole
Uvular deviation in PTA
To the contralateral side
Infections mononucleosis pathophyz
EBV (Ebstein-Barr virus) selectively infects B-lymphocytes (90%); CMV and other viruses less commonly involved (10%)
Dx test for Mono
Heterophile antibodies in serum (Monospot test, Paul Bunnell test; rapid kits 85% sensitive, ~100% specific) will be 40% negative in first 2-3 weeks
Presence of 80-90% mononuclear and 10% atypical lymphocyets on smear
IgM firs tmonth only; IgG appears at 1 week, present for life
Abx in Mono
Antimicrobials for secondary infections (amp/amox may cause a severe rash from hypersensitivity)
Sleep physiology of newborn
<2 months
Preterm: sleep staged differently; quiet, active, and intermediate sleep; quiet is similar to NREM, active is similar to REM (~50%), intermediate is mix
Term: sleep/wake differentiation occurs by 37 weeks GA
Sleep physiology of infant
2mo-1yr
Percentage of REM sleep declines
Sleep physiology of toddler
1-3 yrs
1 yr: 30% REM, may nap 1-2 hours/day, normal sleep time 13-15 hours
2 yr: 25% REM similar to adults, separation anxiety and night awakenings
Sleep physiology of school age/prepubescent
5 yr: 20% REM, naps not required, adult-like sleep cycles (90-110 minutes)
6-12 yrs: slow wave sleep is maximal, then abruptly drops off in puberty and declines throughout adulthood; circadian phase preferences develop (morning versus evening); parasomnias may develop
Sleep physiology of adolescent
should get 9 hrs of sleep
at risk for behavior-induced insufficient sleep syndrome
Peds sleep-disordered breathing
Defined as: abnormal respiratory pattern during sleep that includes snoring, mouth breathing, and pauses in breathing
Spectrum of SDB
Snoring (10%)
Upper airway resistance syndrome
Obstructive hypoventilation
Obstructive sleep apnea (OSA: 1-3%)
Pathophyz of SDB
Upper airway osbruction from adenotonsillar hyperplasia MC
Obesity (25-40% have SDB
Carniofacial anomalities/syndromes
Prematurity
Daycare exposure and freq URI, smoking exposure
Ethnicity (Af-am MC)
Neuromuscular disorders
Indications for PSG in SDB (AAO-HNS CPG 2011)
- Prior to tonsillectomy in presence of obesity, Down syndrome, craniofacial anomalies, neuromuscular disorders, sickle cell disease, mucopolysacchridoses
- Discordance between tonsillar size and SDB symptoms
Peds OSA complications
DD, FTT (increased energy expenditure, feeding impairment, reflux from high negative intrathoracic pressures), cardiorespiratory complications (cor pulmonale, pectus excavatum), behavioral disorders
Peds PSG sleep scoring: apneic events
Drop in airflor >=90% (oronasal thermal sensor) that lasts the duration of 2 baseline breaths (does NOT req 10 seconds)
Peds PSG sleep scoring: hypopneic events
Nasal air pressure decreases by >= 30% lasting the duration of 2 breaths and must be associated with a >=3% oxygen desaturation or an arousal/awakening
Peds PSG sleep scoring: respiratory effort related arousals/RERAs
nasal air pressure flattens and decreases in amplitude but NOT >= 30% and is associated with snoring, noisy breathing, incerased work of breathing or elevation of end-tidal or transcutaneous PCO2
Peds PSG sleep scoring: AHI
Apnea-hypopnea index, number of obstructive apneas and hypopneas per hour of sleep
OSA scoring scale (AAO-HNS CPG 2012)
- Normal AHI <= 1, O2 nadir >92%
- Mild OSA: AHI >1, <= 5
- Mod OSA: AHI >5, <= 10
- Severe OSA: AHI >10, O2 nadir <80%
Hypoventilation syndrome
if arterial (or end-tidal) CO2 >50 mm Hg for >25% of total sleep time
Central sleep apnea
similar to adults but event must last >= 20 seconds or 2 missed breaths with an arousal/awakening or with a >=3% desaturation
Consider medical causes, Arnold Chiari malformation, metabolic disorders, cardiac disease, medications (opioids), high altitude
Primary sleep apnea of infancy
Central apnea of >=20 seconds associated with immaturity of brainstem respiratory control centers
Lead to bradycardia and hypoxemia, may require resuscitation or stimulation
More common in preemies
Periodic breathing
series of 3 episodes of central apneas lasting >3 seconds each occuring within 20 seconds
Frequent in Arnold-Chiari patients
Congenital central hypoventilation syndrome (Ondine’s Curse)
PHOX2b gene mutation causing a failure of autonomic control of breathing at night
Rx: tracheotomy and long-term ventilation during sleeps/naps
Sudden infant death syndrome
Abrupt, unanticipated death of unknown etiology
RFs: male, preemie, prone position sleep, multiple births, maternal young age (teen), family hx
Prevent by supine position sleep (“back to sleep”), firm mattress, no bed sharing, removal of surrounding soft objects
Behavior insomnia of childhood: sleep-onset type
caused by reliance on an inappropriate sleep association and inability fo “self soothe” (e.g., rocking, bottle, parents’ bed)
Rx: CBT, extinction (“crying it out”), gradually reduced parent intervention, daytime naps, discontinued feeding after 6 months, consider preemtive scheduled awakenings (!5 minutes before anticipated awakening)
Behavior insomnia of childhood: limit-setting type
characterized by parents’ inability to establish appropriate sleep behaviors, “child stalling” or refusals
Rx: CBT, consistent bedtime, parent education, may provide a transitional object (e.g., stuffed animal, blanket)
Patient care recommendations from AAO-HNS CPG 2011
- Preop: avoid anxiolytics or sedatives; if nec, then monitor for hypoventilation and hypoxemia
- Intraop: intraop Decadron reduces postop nausea/vomiting; SDB children are at increased risk of airway collapse and delayed emergency; avoid or reduce intraop opioids for SDB children; local anesthesia injection should NOT be used
- Postop: SDB children require more intensive nursing care and monitoring; strong recc against periop Abx (not shown to reduce postop hemorrhage, pain, or return to normal function significantly)
Pain control after tonsillectomy
Tylenol and ibuprofen
Codeine not recc; postop opiates must be used with caution (abnormal metabolism related to CYP2D6, causing overproduction of metabolites)
Ketorolac contraindicated due to increased bleeding risk
Monitored overnight stay after tonsillectomy
Considered in <3 years old, syndromic, comorbidities, obesity (>99th percentile BMI), live >1 hour from hospital, unreliable parents, bleeding disorder, or severe OSA (AHI >=10, O2 nadir <80%)
REM rebound may occur in severe OSA patients after 18hrs, which may cause hypoventilation and hypoxemia
ICU admission after tonsillectomy
Severe OSA, comorbidities that cannot be managed on a ward, significant airway obstruction and O2 desat in recovery room unresponsive to repositioning and O2
Tonsillectomy indications
- Tonsillar hyperplasia resulting in SDB or OSA associated with cor pulmonale
- Suspected malignancy
- Tonsillitis resulting in febrile convulsions (may require Quinsy tonsillectomy)
- Persistent or recurrent tonsillar hemorrhage
- FTT (not attiributable to other causes)
What is Paradise criteria?
Relative indication for tonsillectomy 7 infections in 1 year 5 infections/yr x2 3 infections/yr x3 (infx defined as sore throat with 1+ more of fever >38.3, cervical adenopathy, tonsillar exudate, or pos strep test)
Most common complications after T&A?
Most common serious complication is bleeding (0.5-5%)
Types of bleeding T&A complications
Three.
- Intraoperative
- Immediate post-op
- Delayed post-op
Describe intraoperative T&A bleeding complications.
Arterial injury such as aberrant carotid artery, retrained tonsillar tissue, tears in posterior pharyngeal wall
Describe immediate postoperative bleeding after T&A
Bleeding <24 hrs post-op. 0.2-2.2%.
Similar to intraoperative, may be due to inadequate hemostasis during surgery typically from vessel spasm
Describe delayed post-op bleeding after T&A
> 24hrs post-op. 0.1-3%.
~5-10 days post-op, due to eschar sloughing
Describe post-op edema after T&A
Due to sudden relief of airway obstruction from long-standing adenotonsillar hyperplasia resulting in a sudden drop in intrathoracic pressure, increased pulmonary blood volume, and increased hydrostatic pressure
May occur immediately or after a few hours
Rx: PEEP, mild diuresis
Describe VPI after T&A
Results from an incompetent velopharyngeal inlet; increased risk with submucosal cleft palate, history of nasal regurgitation, or preoperative hypernasality
Rx: speech therapy (typically resolves); if persistent pharyngeal flap or palatal lengthening and consider testing for 22q11
Describe Grisel syndrome
Atlantoaxial (C1-C2) subluxation resulting in spread of inflammation from the OP to the cervical ligaments resulting in laxity and spinal cord compression; rare, increased risk with Down syndrome
Rx: orthopedic consult, may need Abx, cervical collar
Ideal age for septoplasty?
After puberty (~15-16 years old)
Describe mandibular distraction osteogenesis
Progressive elongation of native mandible and soft tissue envelope by performing bilateral sagittal osteotomies and placement of internal and external distraction devices
indications for MDO
Micrognathia/retrognathia, airway obstruction, feeding difficulties, tracheostomy decannulation, severe obstructive sleep apnea, hemifacial microsomia
Commonly performed for Pierre-Robin Sequence and Treacher Collins, Nager, velocardiaofacial and Pfeiffer syndromes
Phases of MDO?
Four.
- Lacenty
- Active distraction
- Consolidation
- Hardware removal
Latency phase of MDO?
First one of four.
1-5 days; shorter in toddlers/young children, wait 5-7 days in adults; allows hematoma formation and platelet-derived growth factor production; if too short may lead to fibrous union and if too long may lead to callus
Active distraction phase of MDO?
1-2 mm/day until supraglottic obstruction relieved
Consolidation phase of MDO?
4-12 weeks
Complication of MDO
Infection, scarring, nerve injury (marg, inferior alveolar, facial nerve), dental injury (tooth bud injury with tooth loss, dentigerous cysts), malocclusion (anterior open bite), poor healing (malunion, nonunion, relapse), device failure, TMJ ankylosis
Most common H&N neoplasm in children
Infantile hemangioma
Origin of infantile hemangioma
Endothelial origin
Presentation of infantile hemangioma
Superficial type presents at birth or within 2 weeks as a white spot (Herald Path) or a small red spot; deep type usually discovered a few weeks after birth
Epidemiology of infantile hemangioma
MC female (3:1 ratio) 10% population incidence
Pathophysiology of infantile hemangioma
Unknown, possibly from disrupted placental cells or stem cells
Histopathology of infantile hemangioma
IHC markers GLUT1 and LeY (Lewis Y antigen)
Biological markers: beta-fibroblast growth factor, urokinase
Stages of infantile hemangioma
- Proliferative <= 12 months old, endothelial cell hyperplasia, elevated mast cells, multilaminar basement membrane
- Involuting 50% regress by 5 years old, 70% by 7 years; fibrosis, decreased cellularity
- Involuted: soft mass of excess skin and fibrofatty tissue, scarring, telangiectasias, atrophy
Types of infantile hemangioma
- Superficial/cutaneous (strawberry or capillary hemangioma): bright strawberry-red color progresses to wind color then grey
- Deep (cavernous hemangioma): covered by skin, appears blue
- Compound: mixed
Define PHACES Syndrome
Posterior cranial fossa anomalies (req MRI)
Hemangioma (facial segmental)
Arterial/carotid anomalies
Cardiac anomaly/Coarctation of the aorta (req cardiac echo)
Eye anomaly
Sternal pit
MC females (90%); consider if large segmental hemangioma
Maffucci Syndrome
Multiple deep hemangiomas +/- visceral vascular lesions
Dyschondroplasia
Chondrosarcoma in 25%
Complications of infantile hemangioma
In 20%
Cosmetic deformity, amblyopia (eye involvement), ulceration (10%), infection, bleeding (rare, reassure that it will not “burst”), airway compromise (laryngeal), thrombocytopenia, and high output cardiac failure (rare)
Dx for Subglottic Hemangioma
Endoscopy (avoid biopy), CT and MRI may confirm diagnosis
PA and lateral neck x-rays may show unilateral or posterior subglottic lesion
Describe cutaneous infantile hemangioma
MAy present anywhere in H&N (concerning in eyelid and orbit)
Common in parotid and oral cavity (lip), 1% of children with a cutaneous lesion will have a subglottic hemangioma
Describe laryngeal infantile hemangioma
Sessile lesions, present with inspiratory or biphasic stridor within the first few months of life that is worse with crying (engorgement), dysphonia, dysphagia (rare)
50% of children with a subglottic hemangioma will have a cutaneous lesion
Describe nasal infantile hemangioma
MC in Little’s area (Kisselbach’s plexus) or inferior turbinate
Describe ear/periauricular infantile hemangioma
May deform the ear or ear canal (CHL)
Describe parotid infantile hemangioma
50% of parotid hemangiomas associated with cutaneous hemangiomas
When should one order ultrasound in infantile hemangioma?
If >3 hemangiomas, consider abdominal ultrasound for occlult lesions (eg liver)
Define complications from infantile hemangioma
VASCO impaired Vision or hearing imparied Swallowing important Cosmetic effect or with ulceration high Output cardiac failure
Rx infantile hemangiomas without complications
Observation, propranolo, oral steroids, surgical excision (cold or pulsed dye laser)
Rx infantile hemangiomas with complications
Propranolol is standard of care for hemangiomas in the proliferative stage, consider trial of oral steroids if >12 months old, consider vincristine for severe cases
Propranolol considerations in infantile hemangiomas
Baseline vital signs, recent normal cardiovascular and pulmonary exams (ECG or glucose screening no longer req w normal exam)
Usually responds within 2-12 weeks; continue until 1 year old then taper
Contraindications include cardiogenic shock, sinus bradycardia, hypotension, greater than first-degree heart block, heart failure, bronchial asthma, and drug hypersensitivity (higher stroke risk in PHACES)
Two types of congenital hemangioma
Congenital hemangioma is present at birth
- RICH: rapidly involuting, involutes by 6-14 months; typically GLUT-1 neg
- NICH: non-involuting, does not involute; GLUT-1 negative. Rx: surgery; consider preoperative angiography with embolization for large lesions.
Define TA and KHE
Tufted angioma (TA) and kaposiform hemangioendothelioma (KHE) are a spectrum of vascular tumors of arteries and veins that are GLUT-1 negative
Describe TA to KHE
Congenital or acquired
>50% present <1 year old
Variable growth and regerssion paterns
Describe KHE growth pattern
Aggressive permeating muscle, soft tissue and bone
Describe TA/KHE histopathology
Hypercellular tufts of capillaries in the reticular dermis
May be associated with dilated lymphatic vessels
Deeper spindle cells indicate KHE
Positive for D2-40 (lymphatic marker)
Describe SSx of TA/KHE
Macules/patches (mottled red), plaques (red-purple, indurated), annular patterns of presentation; tenderness; hyperhidrosis, hypertrichosis (hard on palpation)
Describe visceral involvement of TA/KHE
Visceral involvement almost always associated with platelet trapping
How to diagnose congenital hemangioma?
CBC, DIC (diffuse intravascular coagulation) panel, MRI, biopsy if needed (may need in >1 location)
Rx for congenital hemangioma
Observation, cryotherapy, pulsed dye laser, surgical excision
Define Kasabach-Merritt Phenomenon
Sequestration of platelets and severe thrombocytopenia, microangiopathic hemolytic anemia, and consumptive coagulopathy in KHE or TA (not infantile hemangioma)
Suspect with rapidly enlarging lesion
Can be life-threatening
Rx Kasabach-Merritt Phenomenon
Drug combinations/chemotherapy (vincristine) or surgery
Define vascular malformations
Vascular channel malformations secondary to a defect in morphogenesis
Characterized as high flow (arteriovenous) or low flow (lymphatic, capillary, venous) malformations
How are vascular malformations different from hemangiomas?
VM are present at birth (although may manifest later secondary to hormonal changes, severe infections near vessels or trauma)
Grows with child (endothelium hypertrophies) and therefore does not regress
Sudden increase in size is concerning
Histopathology of vascular malformations
Mature endothelium with normal mitosis (versus hemangioma, which has increased mitosis in the proliferative phase
Associated symptoms of vascular malformations
Sturge-Weber syndrome
Klippel-Trenaunay syndrome (KTS; combination of capillary, venous, and lymphatic types of VM)
Parkes-Weber syndrome (arteriovenous and capillary malformation in association with skeletal/soft tissue hypertrophy)
Blue rubber bleb (venous malformation with associated GI lesions)
Sturge-Weber syndrome
(SWS; unilateral port-wine stain in CN V1 distribution with extension to the leptomeninges)
Klippel-Trenaunay syndrome
(KTS; combination of capillary, venous, and lymphatic types of VM)
Parkes-Weber syndrome
(arteriovenous and capillary malformation in association with skeletal/soft tissue hypertrophy)
Blue rubber bleb
(venous malformation with associated GI lesions)
Types of low flow vascular malformations
- Lymphatic malformation
- Capillary malformation
- Venous malformation
Epidemiology of lymphatic malformations
90% present <3 years old (65% present at birth)
May persist in adulthood
Associated with venous malformations (lymphatics and venous system develop concurrently)
Histopathology of lymphatic malformation
Abnormal development or obstruction of primitive jugular lymphatics that undergo irregular growth with lymphoendothelial hyperplasia
Increase in mast cells during proliferative phase, fewer mast cells during the involutional stage (D2-40 stain)
Classification of lymphatic malformation
Macrocystic (>=1 cysts, >= 2mL)
Microcystic (<2 mL)
Mixed (formerly called cystic hygroma and lymphangioma)
What are cystic hygroma and lymphangioma now?
Mixed lymphatic malformation
Staging of lymphatic malformation
Modified de Serres I: unilateral infrahyoid II: unilateral suprahyoid III: unilateral infrahyoid and suprahyoid IV: bilateral infrahyoid and suprahyoid V: bilateral infrahyoid and suprahyoid VI: bilateral infrahyoid and suprahyoid VII: retropharyngeal M: mediastinal extension (I-III typically macrocystic and IV-VI typically microcystic)
SSx of lymphatic malformation
Soft painless compressible mass (lymphatic dilation) with skin discoloration (macrocystic); soft noncompressible masses with mucosal or skin vesicles (microcystic); both types may cause dysphagia, dyspnea; may remain dormant; may become painful with acute infection
Dx lymphatic malformation
Physical exam, MRI
Complications from lymphatic malformation
Respiratory distress from respiratory tract compression, infection (common, presents as a rapid enlargement of the malformation), disfigurement, spontaneous hemorrhage into macrocysts causing rapid enlargement
Rx lymphatic malformation
Sclerotherapy (doxycycline, bleomycin), sirolimus (rapamycin), early conservative excision when symptomatic (spare vital structures), low rate of recurrence if compeltely removed (only 50% if gross tumor remains); if detected prenatally and airway concerns, may require EXIT procedure
Define capillary malformation
Also called port-wine stain, stork bite, salmon patch (nape of the neck) or angel kiss (forehead)
Classification of capillary malformation
Medial (salmon patch, usually lightens and disappears with time)
Lateral (port-wine stain, always persists, usually follows CN V on face and darkens with time; involvement of lateral thigh and knee indicates Klippel-Trenaunay syndrome
SSx of capillary malformation
Bright red, scarlet at birth fades to pink in infants but then gradually enlarges and deepens to dark purple by adulthood
Medial type is lighter at birth
Rx of capillary malformation
Pulsed dye laser
Define venous malformation
Ectatic venous channel network which has a tendency to grow slowly in childhood, then expand rapidly with hormonal changes or trauma
Often involves the aerodigestive tract
SSx of venous malformation
Compressible mass, skin discoloration (none to dark blue/purple); airway obstruction, dysphagia,; symptoms often get worse with recumbent position or Valsalva
Dx of venous malformation
Physical exam, Doppler ultrasound, MRI
Rx of venous malformation
Surgery, laser, sclerotherapy (sodium tetradecyl sulfate, ethanol), anticoagulatns for symptomatic thrombosis
Types of high flow vascular malformations
Only arteriovenous malformation (AVM)
Define arteriovenous malformation
Shunting between the arterial systems via anomalous capillary beds
Growth of AVM
typically small and stable in childhood, then rapid growth in 2nd-3rd decade of life with puberty and/or trauma
AVM Staging
Schobinger staging
Stage I: quiescent
Stage II: expansion (bruit, thrill, warm throbbing)
Stage III: destruction (ulcers, bleeding, bony changes)
Stage IV: systemic (congestive heart failure, left ventricular hypertrophy)
SSx of AVM
Warm, pulsatile intermittently growing lesion with skin discoloration; bruit
Dx of AVM
Physical exam, pulsed Doppler, CTA, MRA and sometimes still digital angiography
Complications from AVM
Local tissue destruction and hemorrhage
Rx for AVM
Embolization; some require surgical excision
When are newborns preferential nasal breathers?
For 6-20 weeks (variable)
When should you suspect nasal obstruction?
Newborns with tachypnea, cyclical cyanosis (worse with feeding, improve with crying) FTT, rhinorrhea, unable to pass 6 French flexible suction catheter
Dx congenital nasal disorders and neonatal nasal obstruction
Assessment for dysmorphisms (telecanthus, broad nasal bridge, nasal pits), ocular discharge, periocular infection/edema, nasal endoscopy, oral exam (palate arching or clefting), CT or MRI if tumor suspicion
DDx of congenital nasal disorders and neonatal nasal obstruction
Rhinitis of the newborn, viral rhinitis, dacryocystocele, prifirom aperture stenosis, midnasal stenosis, choanal atresia, tumors (encephalocele, glioma, dermoid, teratoma, hemangioma), septal deviation (birth trauma, rare)
Rx for congenital nasal disorders and neonatal nasal obstruction
Address underlying cause, for bilateral obstruction or airway distress consider an oral cannula (McGovern nipple, oral airway) prior to intubation, tracheotomy reserved for severe cases
What is a McGovern nipple?
Large nipple with end cut off
Define idiopathic rhinitis of the newborn
Considered after negative work-up for nasal obstruction and other causes of rhinitis
Pathophysiology of idiopathic rhinitis of the newborn
Possibly secondary to maternal estrogen, infectious (congenital syphilis “snuffles”, chlamydia), early allergic rhinitis (high prevalence of familial atopy), ciliary dyskinesia, hypothyroidism
SSx of idiopathic rhinitis of the newborn
Abundant rhinorrhea (mucoid), nasal mucosal edema, stertor, tachypnea, poor feeding
Rx for idiopathic rhinitis of the newborn
Frequent suctioning, nasal saline sprays, nasal steroid drops, avoid stenting if possible
Peds allergic rhinitis associated SSx
decreased energy and stamina, sleep deprivation, limitaitons in organized sports and outdoor activities, poor school performance
Risk factors for peds allergic rhinitis
urban living, obesity, no breast feeding, environmental tobacco smoke
Complications of peds allergic rhinitis
Asthma exacerbation (asthma in 48% of AR patients, but rhinitis in 80% of asthma patients, risk of asthma related to severity and duration of rhinitis), sinusitis, otitis media, sleep disorders, craniofacial abnormalities (upturned nose or “allergic salute,” elongated “adenoid” facies), decreased cognitive functioning
When to consider immunotherapy?
Sublingual and intradermal immunotherapy may be considered >4-5 years old, may be protective against new sensitivities and development of asthma
Pathophysiology of choanal atresia
Persistence of the bucconasal membrane or abnormal migratio of neural crest cells into the nasal vault resulting in a complete bony (30%), mixed bony-membraneous (70%), or membranous (rare) defect of the posterior nasal cavity
Bony components are from the pterygoid plate and vomer
Epidemiology of choanal atresia
MC females; unilat (65%; R>L)
SSx of choanal atresia
Unilateral presents with rhinorrhea, nasal obstruction
Bilateral presents at birth with cycles of apnea and cyanosis followed by crying due to obligate nasal respiration in neonates
Dx choanal atresia
Mirror to detect condensation, attempt transnasal passage of 6 French catheter, attempt nose blowing with an occluded nostril, nasal endoscopy, CT
Associated syndromes with choanal atresia
CHARGE syndrome (MC concurrent syndrome in bilateral atresia, 50%), Apert, Treacher Collins, Crouzon, trisomy 21, 22q11 deletion
Rx for choanal atresia
Surgical repair via transnasal (usually endoscopic), transantral (creation of large cavity for recurrent cases), transseptal, or transpalatal (classic operation, may disrupt orthodontic growth, less common today) appraoch
Post-op stenting less common with endoscopic repair; unilateral atresia may be repaired electively
Bilateral atresia must be addressed during first weeks of life, early meausre includes establishing an oral airway (eg, McGoevrn nipple) intubation not usualyl required
DDx unilateral peds nasal mass
Vascular (JNA, hemangioma, AVM) Infectious/inflammatory (polyp, rhinolith) Neoplastic/mass (encephalocele, glioma, neurofibroma) Drug-related Idiopathic Congenital (nasolacrimal duct cyst) Autoimmune/allergic Truamatic (foreign body) Endocrine
Fonticulous frontalis
Embryologic space that normally fuses during teh development of the frontal bones
Prenasal space
Embryologic spaces between the nasal bone and nasal cartilage
Foramen cecum
Region between ethmoid and frontal bones, connects with prenasal space
Pathophysiology of neurogenic tumors
Dura projects through the foramen cecum, the fonticulus frontalis (intranasally), or the prenasal space into skin (extranasally) with failure of anterior neuropore closure
Dx neurogenic tumors
MRI/CT to evalute intracranial extention
Do not biopsy
Pathophysiology of encephalocele
failured closure of neuropore or failed migration of neural crest cells results in ependymal-lined meninges herniation through the base of skull
Communicates with subarachnoid space (CSF filled)
Types of encephalocele by layers
MC lumbar-sacral region
- Meningocele: meninges only
- Meningoencephalocele: meninges and brain elements
- Meningoencephalocystocele: meninges, brain, and a part of the ventricular system
Types of encephalocele by location
- Occipital: most common (75%)
- Sincipital (frontoethmoidal): defect between frontal and ethmoid bones at the foramen cecum; nasofrontal (glabellar lesion), nasoethmoidal (lateral nose lesion), and nasoorbital (medial orbital wall lesion) subtypes
SSx of encephalocele
Bluish, soft, pulsatile, compressible mass that changes with straining and crying, transilluminates
Intranasal encephaloceles often confused with nasal polyps
Dx of encephalocele
CT/MRI reveals bony defect
Furstenburg test
What is Furstenburg test?
Compression of IJ cuases increases in size of the mass due to increased CSF pressure
Complications of encephalocele
meningitis, nasal obstruction, cosmetic deformity, hydrocephalus
Rx for encephalocele
surgical excision similar to glioma, must also close the dural defect to prevent CSF leak and brain herniation (neurosurgical consultation)
Pathophysiology of nasal glioma
Sequestered glial tissue or “pinched off encephalocele” results in unencapsulated collection of heterotopic glial cells
15% connect to dura by a fibrous stalk
Location of nasal glioma
Extranasal (60%) or intranasal (30%), typically not midline
SSx of nasal glioma
Firm, nonpulsatile mass, skin-covered, does nto change in size with straining, noncompressible, does not transilluminate, may look like intranasal polyp, broad nasal dorsum
Dx of nasal glioma
CT and/or MRI to evaluate for intracranial extension (15%), neg Furstenburg test